Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.42 |
| ▸ | FURIN | P09958 | 10/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.37 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KLK7 | P49862 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23629902 | 0.87 | MEN1 (0.44) | C3AR1FURINPRSS1MEN1KMT2A | |
| SCHEMBL24191073 | 0.85 | C3AR1 (0.42) | C3AR1FURINPRSS1CTDSP1NOD1 | |
| SCHEMBL30317564 | 0.85 | C3AR1 (0.42) | C3AR1FURINPRSS1CTDSP1NOD1 | |
| SCHEMBL31319761 | 0.84 | C3AR1 (0.41) | C3AR1FURINPRSS1CTDSP1NOD1 | |
| SCHEMBL29620243 | 0.84 | C3AR1 (0.42) | C3AR1FURINPRSS1CTDSP1NOD1 | |
| Trifluoroacetic Acid SCHEMBL23630136 | 0.82 | QRFPR (0.39) | C3AR1FURINPRSS1CTDSP1SHMT1 | |
| SCHEMBL30317553 | 0.81 | C3AR1 (0.41) | C3AR1FURINNOD1MEN1KMT2A | |
| SCHEMBL17581833 | 0.81 | CTSS (0.52) | C3AR1MEN1KMT2AGAACTSS | |
| SCHEMBL12283739 | 0.81 | CTSS (0.52) | C3AR1MEN1KMT2AGAACTSS | |
| SCHEMBL13436631 | 0.81 | CTSS (0.52) | C3AR1MEN1KMT2AGAACTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115546-A1 | LINKERS FOR ANTIBODY DRUG CONJUGATES | UNIV TEXAS (US) | 2025-04-10 | — | — | US | disclosed |
| CN-111065623-B9 | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-10-25 | — | — | CN | disclosed |
| CN-118652192-A | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-09-17 | — | — | CN | disclosed |
| US-12084403-B2 | Linkers for antibody drug conjugates | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-09-10 | — | — | US | disclosed |
| CN-111065623-B | Linker for antibody drug conjugates | 德克萨斯州大学系统董事会 | 2024-09-03 | — | — | CN | disclosed |
| US-20240059647-A1 | LINKERS FOR ANTIBODY DRUG CONJUGATES | UNIV TEXAS (US) | 2024-02-22 | — | — | US | disclosed |
| US-11629122-B2 | Linkers for antibody drug conjugates | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115546-A1 | LINKERS FOR ANTIBODY DRUG CONJUGATES | CD47, EPCAM, SDCBP | C3AR1 1357/4885FURIN 572/4885PRSS1 4421/4885 |
| US-12084403-B2 | Linkers for antibody drug conjugates | CD47, EPCAM, SDCBP | C3AR1 1357/4885FURIN 572/4885PRSS1 4421/4885 |
| US-20240059647-A1 | LINKERS FOR ANTIBODY DRUG CONJUGATES | CD47, EPCAM, SDCBP | C3AR1 1357/4885FURIN 572/4885PRSS1 4421/4885 |
| US-11629122-B2 | Linkers for antibody drug conjugates | CD47, EPCAM, FCGRT | C3AR1 1121/4885FURIN 570/4885PRSS1 4454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.